ANI Pharmaceuticals | ANIP - Ebitda





Ebitda Alterar Data
AbbVie USD 3.69B 1.68B 2026-03
ANI Pharmaceuticals USD 71.6M 6.69M 2026-06
Aurora Cannabis CAD 3.7M 14.78M 2026-03
Canopy Growth CAD -137M 134.13M 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Hikma Pharmaceutical USD 369M 84M 2024-12
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novartis USD 5.41B 431M 2026-03
Omeros USD -47.96M 7.39M 2023-09
Perrigo USD 141.6M 1.34B 2026-03
Sun Pharmaceuticals INR 44.18B 4.63B 2026-06
Teva Pharmaceutical Industries USD 474M 581M 2026-06